Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2031200085Completed
Open-label, single-arm trial of EP-HMRG. Primary endpoints: Safety assessment of EP-HMRG (GCP-002) and Pharmacokinetics of EP-HMRG (GCP-002) and HMRG. Started Aug 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2031200085.